Penobscot Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$266K Buy
1,047
+24
+2% +$5.59K 0.07% 100
2026
Q1
$250K Buy
1,023
+4
+0.4% +$932 0.07% 95
2025
Q4
$211K Buy
+1,019
New +$202K 0.07% 103
2024
Q2
Sell
-1,264
Closed -$200K 76
2024
Q1
$200K Buy
+1,264
New +$201K 0.13% 75
2023
Q4
Sell
-1,585
Closed -$247K 72
2023
Q3
$247K Buy
+1,585
New +$262K 0.19% 57
2023
Q1
Sell
-1,147
Closed -$203K 65
2022
Q4
$203K Sell
1,147
-80
-7% -$13.8K 0.18% 60
2022
Q3
$200K Buy
1,227
+3
+0.2% +$508 0.19% 60
2022
Q2
$217K Buy
1,224
+38
+3% +$6.77K 0.21% 58
2022
Q1
$210K Buy
1,186
+3
+0.3% +$510 0.19% 60
2021
Q4
$202K Sell
1,183
-231
-16% -$37.8K 0.17% 56
2021
Q3
$228K Buy
1,414
+3
+0.2% +$512 0.21% 50
2021
Q2
$232K Buy
+1,411
New +$234K 0.22% 46

Other funds holding JNJ

Penobscot Wealth Management's JNJ Position: Q2 2026 in Review

Penobscot Wealth Management increased its Johnson & Johnson (JNJ) stake by 2.3% in Q2 2026, buying an estimated $5.59K and bringing the position to 1,047 shares worth $266K. The position accounts for 0.07% of the portfolio, ranked #100.

Penobscot Wealth Management first reported a position in JNJ in Q2 2021 and has held it in 12 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Penobscot Wealth Management held 1,047 shares of Johnson & Johnson worth $266K as of Q2 2026.
  • Penobscot Wealth Management bought 24 Johnson & Johnson shares in Q2 2026, an estimated $5.59K.
  • Johnson & Johnson made up 0.07% of Penobscot Wealth Management's portfolio in Q2 2026, its #100 holding.
  • Penobscot Wealth Management first reported a position in Johnson & Johnson in Q2 2021 and has held it in 12 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Penobscot Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.